Loading...
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer
Small cell lung cancer (SCLC) is a leading cause of cancer death worldwide, with few treatment options. Rovalpituzumab tesirine (Rova‐T) is an antibody‐drug conjugate that targets delta‐like 3 on SCLC cells to deliver a cytotoxic payload directly to tumor cells. In this study, the cardiac safety pro...
Na minha lista:
| Udgivet i: | Clin Transl Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993269/ https://ncbi.nlm.nih.gov/pubmed/33340277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12928 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|